Lucas has updated the Metacon research report following the latest news 
In our view, the recently announced capital raise reduces financial risks and allows the company to execute its order backlog and help convert part of its sales pipeline, at least in the short term. Due to the overall structure of the offering, we expect it to be successful. With short-term financing soon secured, Metacon can once again focus on executing its commercialization plans. After updating our valuation assuming the rights issue is fully subscribed, we reiterate our Accumulate recommendation but lower our target price to SEK 0.23 per share (prev. SEK 0.40 per share), primarily due to a higher-than-expected dilution effect.